Sarah Walter

13.4k total citations · 1 hit paper
50 papers, 2.3k citations indexed

About

Sarah Walter is a scholar working on Psychiatry and Mental health, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Sarah Walter has authored 50 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Sarah Walter's work include Migraine and Headache Studies (12 papers), Dementia and Cognitive Impairment Research (10 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Sarah Walter is often cited by papers focused on Migraine and Headache Studies (12 papers), Dementia and Cognitive Impairment Research (10 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Sarah Walter collaborates with scholars based in United States, United Kingdom and Netherlands. Sarah Walter's co-authors include Marcelo E. Bigal, Alan M. Rapoport, Paul Aisen, Rema Raman, Wim A. Buurman, Tim G. A. M. Wolfs, Bart de Vries, William J. Jagust, Michael W. Weiner and Clifford R. Jack and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and American Journal Of Pathology.

In The Last Decade

Sarah Walter

49 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

2022 130 citations Michael S. Rafii, Reisa A. Sperling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Walter United States	23	1.2k	772	385	351	280	50	2.3k
Mark W. J. Strachan United Kingdom	40	761 0.7×	1.2k 1.6×	185 0.5×	567 1.6×	210 0.8×	146	5.8k
Magdalena Korecka United States	25	1.0k 0.9×	899 1.2×	76 0.2×	662 1.9×	179 0.6×	49	2.7k
Peter Kapeller Austria	33	837 0.7×	433 0.6×	418 1.1×	294 0.8×	312 1.1×	55	4.0k
Walter Gianni Italy	31	630 0.5×	619 0.8×	140 0.4×	377 1.1×	333 1.2×	78	3.1k
Yili Pritchett United States	34	805 0.7×	1.3k 1.7×	395 1.0×	327 0.9×	585 2.1×	57	4.4k
Kari Kervinen Finland	34	482 0.4×	1.0k 1.3×	276 0.7×	519 1.5×	43 0.2×	82	3.5k
Mitsuhiro Yoshita Japan	33	919 0.8×	718 0.9×	87 0.2×	192 0.5×	349 1.2×	70	3.6k
Robert S. Sheldon Canada	39	937 0.8×	511 0.7×	110 0.3×	349 1.0×	176 0.6×	181	7.3k
Edward Bollen Netherlands	23	401 0.3×	510 0.7×	146 0.4×	278 0.8×	251 0.9×	41	4.4k
Sanaz Sedaghat United States	24	433 0.4×	503 0.7×	74 0.2×	274 0.8×	104 0.4×	64	2.3k

Countries citing papers authored by Sarah Walter

Since Specialization

Citations

This map shows the geographic impact of Sarah Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Walter more than expected).

Fields of papers citing papers by Sarah Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Walter. The network helps show where Sarah Walter may publish in the future.

Co-authorship network of co-authors of Sarah Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Walter. A scholar is included among the top collaborators of Sarah Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Walter. Sarah Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colman, Nora, et al.. (2024). The Business Case for Simulation-based Hospital Design Testing; $90M Saved in Costs Avoided. Pediatric Quality and Safety. 9(6). e775–e775.

Walter, Sarah, et al.. (2022). Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?. Journal of Alzheimer s Disease. 90(3). 1001–1009. 3 indexed citations

Aisen, Paul, Gustavo Jimenez‐Maggiora, Michael S. Rafii, Sarah Walter, & Rema Raman. (2022). Early-stage Alzheimer disease: getting trial-ready. Nature Reviews Neurology. 18(7). 389–399. 74 indexed citations

Wehmeyer, Malte H., Thomas Horvatits, Anika Buchholz, et al.. (2022). Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials. 23(1). 302–302. 8 indexed citations

Walter, Sarah, et al.. (2021). Can Virtual Scientific Conferences Facilitate Two-Way Learning between Dementia Researchers and Participants?. The Journal of Prevention of Alzheimer s Disease. 8(3). 387–388. 3 indexed citations

Walter, Sarah, Taylor Clanton, Oliver Langford, et al.. (2020). Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD). The Journal of Prevention of Alzheimer s Disease. 7(4). 219–225. 26 indexed citations

Naß, Norbert, Sarah Walter, Dörthe Jechorek, et al.. (2017). High neuronatin (NNAT) expression is associated with poor outcome in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(1). 23–30. 17 indexed citations

Subramanian, Raju, Xiaochun Zhu, Steven W. Louie, et al.. (2016). Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide). Drug Metabolism and Disposition. 44(8). 1319–1331. 28 indexed citations

Walter, Sarah & Marcelo E. Bigal. (2015). TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine. Current Pain and Headache Reports. 19(3). 6–6. 35 indexed citations

10.

Alexander, Shawn T., Thomas C. Hunter, Sarah Walter, et al.. (2015). Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action. Molecular Pharmacology. 88(5). 853–865. 65 indexed citations

11.

Bigal, Marcelo E. & Sarah Walter. (2014). Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity. CNS Drugs. 28(5). 389–399. 47 indexed citations

12.

Walter, Sarah, Amos Baruch, Shawn T. Alexander, et al.. (2014). Comparison of AMG 416 and cinacalcet in rodent models of uremia. BMC Nephrology. 15(1). 81–81. 20 indexed citations

13.

Walter, Sarah, et al.. (2014). Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide. mAbs. 6(4). 871–878. 34 indexed citations

14.

Bigal, Marcelo E., et al.. (2014). Cardiovascular and Hemodynamic Parameters in Women Following IV Administration of LBR-101, a Monoclonal Antibody Against CGRP (P7.198). Neurology. 82(10_supplement). 1 indexed citations

15.

Walter, Sarah, Amos Baruch, James Tomlinson, et al.. (2013). Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients. Journal of Pharmacology and Experimental Therapeutics. 346(2). 229–240. 84 indexed citations

16.

Walter, Sarah, Leon Chen, Atsushi Kurihara, et al.. (2011). Distribution of KAI-9803, a Novel δ-Protein Kinase C Inhibitor, after Intravenous Administration to Rats. Drug Metabolism and Disposition. 39(10). 1946–1953. 36 indexed citations

17.

Hamilton, Gillian, Jo Knight, Nicola Archer, et al.. (2006). Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer's disease. Neuroscience Letters. 401(1-2). 77–80. 7 indexed citations

18.

Wolfs, Tim G. A. M., Bart de Vries, Sarah Walter, et al.. (2005). Apoptotic Cell Death Is Initiated During Normothermic Ischemia in Human Kidneys. American Journal of Transplantation. 5(1). 68–75. 41 indexed citations

19.

Vries, Bart de, Sarah Walter, Tim G. A. M. Wolfs, et al.. (2004). Exogenous alpha-1-Acid Glycoprotein Protects against Renal Ischemia-Reperfusion Injury by Inhibition of Inflammation and Apoptosis. Transplantation. 78(8). 1116–1124. 33 indexed citations

20.

Cook, Lynnette J., Luk Ho, Lin Wang, et al.. (2004). Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 132B(1). 5–8. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact